Current MRD studies in T-cell acute lymphoblastic leukemia (T-ALL) mainly use T-cell receptor gamma, delta and SIL-TAL1 gene rearrangements as MRD-PCR targets. However, low frequency or limited diversity of these markers restricts the number of evaluable patients, particularly because two markers are recommended for MRD monitoring. Hence, we developed a new strategy implementing the TCR beta (TCRB) locus for MRD quantification. The frequency and characteristics of complete and incomplete TCRB rearrangements were investigated in 53 childhood and 100 adult T-ALL patients using the BIOMED-2 multiplex PCR assay. Clonal rearrangements were identified in 92% both childhood and adult T-ALL (Vb-Db-Jb rearrangements in 80%, Db-Jb rearrangements in 53%). Comparative sequence analysis of 203 TCRB recombinations revealed preferential usage of the 'end-stage' segment Jb2.7 in childhood T-ALL (27%), whereas Jb2.3 was most frequently involved in adult T-ALL (24%). In complete rearrangements, three downstream Vb segments (19-1/20-1/21-1) were preferentially used. Subsequently, a TCRB real-time quantitative PCR assay to quantify MRD with 13 germline Jb primer/probe combinations and allele-specific oligonucleotides was developed and applied to 60 clonal TCRB rearrangements. The assay allowed the detection of one leukemic cell within at least 10 4 polyclonal cells in 93% of cases and will be of high value for future MRD studies.
Introduction
Although modern treatment induces complete remission in more than 80% of patients with T-cell acute lymphoblastic leukemia (T-ALL), 1,2 most patients still harbor substantial numbers of leukemia cells after induction. Despite intensive postremission therapy many T-ALL patients relapse, mainly during or shortly after the end of therapy.
1,2 Individualization of ALL treatment might improve the outcome and long-term quality of life. This may be achieved through the detection and quantification of subclinical levels of residual leukemia (MRD), thereby providing important information on the effectiveness of treatment and the risk of an impending relapse. Several studies, mainly in childhood ALL, have shown that MRD is an independent prognostic factor [3] [4] [5] [6] [7] [8] [9] and sequential and sensitive MRD quantification allows a precise risk group classification. 8, 9 In this context, significant differences in the kinetics of MRD have been reported to occur in T-ALL patients compared to those with B-cell precursor ALL, 6, 7, 9 although only few MRD studies focus on T-ALL.
A technique that allows a simple, precise and sensitive quantification of MRD in ALL is the real-time quantitative PCR (RQ-PCR) of clonally rearranged immune genes. [10] [11] [12] [13] [14] [15] [16] So far, mainly clonal T-cell receptor gamma (TCRG) and delta (TCRD) gene rearrangements as well as SIL-TAL1 fusion genes have been used as PCR tools for MRD quantification in T-ALL. [1] [2] [3] 8, [17] [18] [19] [20] [21] However, the SIL-TAL1 fusion genes are detected in only 5-25% of T-ALL patients, 1, 22 and also clonal TCRD gene rearrangements are found in just about 50% of patients. 23, 24 In addition, crosslineage immunoglobulin heavy-chain rearrangements can serve as clonal markers in T-ALL, but they are also relatively rare. 25 In contrast, the vast majority of T-ALL demonstrates TCRG gene rearrangements, but quantitative PCR approaches often do not result in satisfactory sensitivity and specificity due to the limited junctional and combinatorial diversity of this locus. 13 As the use of at least two clonal immune gene markers is recommended for PCR-mediated MRD monitoring, 2, [26] [27] [28] additional PCR targets for MRD quantification in T-ALL are highly warranted.
Clonal TCR beta (TCRB) gene rearrangements theoretically represent ideal MRD targets because the extensive combinatorial repertoire of TCRB rearrangements and their large hypervariable region should allow a highly sensitive and specific detection of clinically occult residual tumor cells by clonespecific PCR. Furthermore, TCRB genes are rearranged in more than 90% of all T-ALL and therefore might be applicable as sensitive MRD-PCR target in most T-ALL patients. 24, 29, 30 However, the extensive germline-encoded TCRB repertoire renders PCR assays for clonality assessment difficult. Attempts to develop DNA-based PCR methods for the detection of clonal TCRB gene rearrangements included the use of highly degenerate consensus primers 31, 32 or application of the timeconsuming multiple tube assay. 33, 34 As these approaches have their limitations in applicability or detection rate, TCRB rearrangements have rarely been used for MRD assessment.
Within the scope of the BIOMED-2 Concerted Action 'PCRbased clonality studies for early diagnosis of lymphoproliferative disorders, we developed a new DNA-based multiplex TCRB PCR approach by design of multiple Vb and Jb primers that cover virtually all functional Vb, Db and Jb gene segments. 35 The assay is applicable for GeneScanning and heteroduplex analysis of the PCR products and also detects the incomplete TCRB rearrangements with a total of three multiplex PCR reactions. 35 This approach allows a simple screening of T-ALL samples for the presence of clonal TCRB gene rearrangements and facilitates the use of TCRB as a target for MRD assessment.
In this report, we applied the BIOMED-2 multiplex TCRB PCR assay for the identification of clonal TCRB gene rearrangements in a large series of pediatric and adult T-ALL patients. Extensive sequence analyses allowed comparative evaluation of genotypic characteristics of clonal TCRB gene rearrangements.
Subsequently, we developed a new RQ-PCR assay for the detection of TCRB gene rearrangements using a limited number of germline Jb TaqMan probes and reverse primers in combination with allele-specific oligonucleotides (ASO). Our data indicate that TCRB gene rearrangements represent an excellent PCR target for sensitive and specific quantification of residual leukemia cells in T-ALL.
Patients, materials and methods

Patient samples
Cell samples were obtained from 153 T-ALL patients (100 adults and 53 children) at initial diagnosis. We also studied several BM follow-up samples of four adult and four childhood patients who were treated according to the German multicenter ALL Study (GMALL) 05/93 or 06/99 protocol or the Dutch Childhood Leukemia Study Group ALL-8 protocol.
Mononuclear cells (MNCs) were isolated from all samples and stored at À801C before DNA extraction. Pooled MNC DNA from equivalent amounts of five healthy donors served as a polyclonal control. DNA was isolated by standard procedures and quantified by spectrometric analysis.
Identification of clonal TCRB rearrangements
The BIOMED-2 multiplex TCRB PCR assay (with 23 consensus Vb, two Db and 13 Jb primers; InVivoScribe, Calsbad, CA, USA) was used for the identification of clonal TCRB rearrangements. 35 Vb primer codes were derived from their corresponding Vb segments using the nomenclature that was proposed by Arden et al. 36 Appropriate positive and negative controls were included in all experiments.
Reaction products were analyzed by heteroduplex analysis as described previously. 37 
Direct sequencing
Clonal PCR products of most T-ALL patients were directly sequenced. The dominant (homoduplex) band within the expected size range was excised and eluted from the polyacrylamide gel and sequenced. Sequence reactions were carried out in both directions, using either the complete set of Vb primers or the Jb Tube A or Jb Tube B primers in a multiplex approach. In case of ambiguous sequence information concerning the NDN, but identifiable Vb or Jb region, sequence reaction was repeated subjecting only the involved Vb or Jb primer to the sequencing reaction. For the analysis of a single incomplete TCRB rearrangement, it was also possible to subject an aliquot of the unpurged PCR product directly to cycle sequencing reaction using the involved Db primer.
For sequencing, the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Weiterstadt, Germany) was used and the reaction products were analyzed on the ABI PRISM 377 automated sequencer (see, for details, Linke et al 38 ). For sequencing of the sense strand of complete TCRB rearrangements 1 pmol of each Vb primer was added and for the antisense strand 10 pmol of each Jb primer. For incomplete rearrangements 10 pmol of the involved Db primer was put into the reaction. Vb, Db and Jb gene segments involved in the recombinations were identified in comparison with published sequences, using the ImMunoGeneTics database (IMGT; http:// imgt.cines.fr, initiator and coordinator: Marie-Paule Lefranc, Montpellier, France). 39 Vb gene designation according to Rowen et al 40 was applied. For correspondence between this nomenclature and Vb primer names derived from designation according to Arden et al 36 (see Figure 1 ). Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al
RQ-PCR primers and TaqMan probes
As described for other immune gene rearrangements, 10, 11, 13, 14, 16, 21, 41 a set of germline TCRB Jb primers and TaqMan probes (Jb1.1-1.6 and Jb2.1-2.7) was constructed according to published Jb sequences. 40, 42 The sequences of the oligonucleotides are given in Figure 2 . In addition, ASO primers were created individually for every single patient complementary to the sequence of the TCRB N-Db-N junctional region using Primer Express 1.0 software (Applied Biosystems) and OLIGO 6.3 software (W Rychlik, Molecular Biology Insights, Inc., Cascado, CO, USA).
RQ-PCR
RQ-PCR was performed on an ABI PRISM 7700 thermal cycler (Applied Biosystems) as described elsewhere. 10 Data were collected and analyzed using the Sequence Detection Software (Applied Biosystems).
Standards were generated from cell samples collected at initial diagnosis that were serially diluted in pooled polyclonal DNA to give final concentrations of (10 0 ), 10 À1 , 10 À2 , 10 À3 , (5 Â 10 À4 ), 10 À4 , (5Â 10 À5 ), 10 À5 , 10 À6 (dilution steps in parenthesis were not always included). Experiments were generally performed in two-to four-fold. Specificity was tested by parallel amplification of normal polyclonal MNC DNA (tested in two-to six-fold).
The sensitivity was defined as the last dilution step generating a positive signal in the absence of a signal from polyclonal control DNA. In case of nonspecific amplification, cycle threshold (C T ) values of the last dilution step with a specific amplification product had to be at least one cycle lower than the lowest C T value found in control MNC DNA (tested in two-to six-fold). The dilution steps yielding quantitative data with respect to the number of allele-specific DNA copies (reproducible range) were defined as follows: (1) maximal difference in C T values of 2.0 between two-to four-fold repetitions. (2) In case of nonspecific amplification, the C T value of the dilution step defining the lower limit of the reproducible range for quantification had to be at least three cycles lower than the C T values of polyclonal control DNA. (3) The standard curve within this reproducible range should have a correlation coefficient of at least 0.95 with (4) a slope between 3.1 and 3.9.
Before analysis of follow-up samples, each RQ-PCR assay was optimized for the highest sensitivity and specificity in testing different annealing temperatures. To confirm DNA integrity and to normalize for differences in amount and quality of DNA samples, the albumin gene was used as an internal reference as described previously. 10 The calculation of MRD levels was based on comparative C T analysis between follow-up samples and standards, MRD values were specified in relation to target copy number in the diagnostic sample.
Results
Frequency of TCRB gene rearrangements in T-ALL
DNA samples of 153 patients (100 adults and 53 children) with T-ALL were studied by TCRB-PCR to identify clonal rearrangements of the TCRB gene. Clonal TCRB gene rearrangements were found in 92% (140/153) of the patients (both adults and children). Frequencies of the different types of rearrangements are summarized in Table 1 . In adult T-ALL, complete TCRB VbDb-Jb recombinations were found in 81% (81/100) of patients and 52% (52/100) of cases demonstrated incomplete Db-Jb joinings. In more than half of the cases (59%) at least two rearrangements were detected, whereas in 33 out of 100 (33%) only one rearrangement was observed (25 complete and eight incomplete rearrangements). As incomplete rearrangements of the Jb2 region can occur on the same allele as Jb1 rearrangements, it is impossible to assess the allelic TCRB gene configuration by PCR analysis only.
In pediatric T-ALL, a total of 52 complete (Vb-Db-Jb) and 37 incomplete (Db-Jb) TCRB gene rearrangements were found in 77% (41/53) and 55% (29/53) of patients, respectively. Comparable with adult T-ALL, in the majority of childhood T-ALL (31/53, 58%) at least two TCRB gene rearrangements were detected. Samples of 17 patients (32%) revealed one clonal TCRB gene rearrangement, including 12 complete and five incomplete rearrangements (Table 1) . Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al
In summary, in both adult and childhood T-ALL clonal TCRB gene rearrangements were detected with the BIOMED-2 TCRB primer set in more than 90% of patients.
In 63 immunophenotyped T-ALL, all sCD3 þ /TCR À (6/6) and sCD3 
TCRB gene segment usage in T-ALL
A total of 203 clonal TCRB junctional regions were sequenced: 126 complete Vb-Jb rearrangements (47 generated from pediatric and 79 from adult T-ALL) and 77 incomplete Db-Jb rearrangements (37 pediatric and 40 adult T-ALL sequences).
Sequence analysis of 126 different complete Vb-(Db)-Jb recombinations allowed the identification of 41 different Vb segments. Their frequencies are summarized in Figure 1 . TCRBV20-1 was most prominent in both adult and childhood T-ALL (11 and 9%). TCRBV19 and 21-1 were also common in both subgroups. Vb segments TCRBV5-1 and 18 occurred more frequently in adult T-ALL, whereas segments 2-1, 5-3 and 7-9 were more frequent in childhood T-ALL.
A Db segment within complete TCRB rearrangements was detected in 70% (adults) and 55% (children), respectively ( Table 2 ). In adult T-ALL, Db1 predominated over Db2 (43 vs 27%), whereas in pediatric T-ALL usage of Db1 and Db2 segments occurred with the same frequency (28% both). In incomplete Db-Jb rearrangements Db2 was preferentially used in both patient groups.
Frequencies of different Jb family members are shown in Table 2 . Predominance of TCRBJ2 rearrangements was characteristic for adult (TCRBJ2/TCRBJ1 ratio of 2.2) and pediatric T-ALL (ratio 2.4). However, discrepancies between the two subgroups were observed when complete and incomplete rearrangements were considered separately. In pediatric T-ALL, a relative increase in Vb-Jb1 rearrangements and Db-Jb2 rearrangements was observed in comparison to adult T-ALL, although this difference did not reach statistical significance (P40.05 by w 2 test). Concerning Jb usage, the most common Jb segment was Jb2.3 in adults and the 'end-stage' segment Jb2.7 in children, while no Jb2.4 or Jb2.6 segments were identified in this series (see, for details, Table 2 ).
Junctional regions of TCRB rearrangements in T-ALL Table 3 summarizes the characteristics of the junctional region sequences of TCRB rearrangements in pediatric and adult T-ALL. Results were largely comparable between these two patient groups. The sizes of the junctional NDN region in complete VbDb-Jb rearrangements differed from 0 to maximally 47 nucleotides with an average of 18.0. Average length of the interposed Db segment was 7.2 nucleotides, the number of deletions and insertions was comparable between adult and childhood T-ALL (see, for details, Table 3 ). The junctional region of incomplete Db-Jb recombinations contained a mean number of 7.2 inserted nucleotides (range 0-22). Trimming at the ends of the Db and Jb gene segments resulted in the deletion of 9.7 (adults) and 10.8 nucleotides (children), equally distributed over Db and Jb.
RQ-PCR analysis
The applicability of the primer/probe set for RQ-PCR was tested in combination with ASO forward primers for 60 TCRB gene rearrangements (48 complete and 12 incomplete rearrangements, Table 4 ). A sensitivity of p10 À3 was reached for all 60 rearrangements and p10 À4 for 56 (93%) of the 60 investigated rearrangements (Tables 4). The standard annealing temperature was 59-601C, but due to nonspecific amplification of polyclonal control MNC DNA the temperature had to be increased to 61-691C in 23 (38%) cases. This was particularly necessary for incomplete TCRB rearrangements (eight out of 12 cases). For complete TCRB rearrangements, elevated annealing temperatures had to be used in 15 out of 48 cases. Despite optimization, the sensitivity did not exceed 10 À3 in two and 5 Â 10 À4 in another two cases. Reasons were high background (2/4 rearrangements) and limited specific amplification (2/4). In case A7115, increasing the annealing temperature led to the disappearance of background and to limited specific amplification, resulting in a sensitivity of 5 Â 10
À4
. Eight additional cases did not fulfill the strict criteria of a reproducible range up to 10 À4 (limit 10 À3 : one Vb-Jb rearrangement; limit 5 Â 10 À4 : five Vb-Jb and two Db-Jb rearrangements). Two problems led to a limited range of quantitative analysis: (1) in three cases normal MNC resulted in amplification with a C T within three cycles from the specific amplification product despite the optimization of annealing temperature. (2) Maximal difference in C T values of two-to fourfold repetitions of the defining dilution step exceeded 2.0 in another five cases.
We tried to identify parameters of TCRB junctional regions, which led to good sensitivities in RQ-PCR. There was no apparent correlation between the reproducible range and Vb gene segments used. However, Jb segments Jb2.3, Jb2.5 and Jb2.7 dominated in TCRB gene rearrangements leading to reproducible ranges 410 À4 (11/12, 92% rearrangements), Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al whereas these Jb gene segments were involved in only 24/48 (50%) of cases with a sensitive reproducible range up to p10 À4 (Po0.05 by w 2 test). No significant dependency on the number of inserted or deleted nucleotides was found. Solely, the number of insertions in complete Vb-Db-Jb recombinations showed a tendency to be higher in recombinations with a higher reproducible range (mean 19.1 vs 13.0).
TCRB gene rearrangements can be selected as targets for MRD with a high chance to reach a sensitivity of at least 10 À4 (96% of complete and 84% of incomplete TCRB rearrangements) and a reproducible range up to 10 À4 in 80% of the cases (40 of 48 (83%) complete and eight of 12 (67%) incomplete TCRB rearrangements).
Quantitation of MRD in follow-up samples
To test the usefulness of the new TCRB RQ-PCR assay for MRD studies in clinical cases, MRD was quantified in a total of 74 follow-up samples of four pediatric and four adult T-ALL with a total of nine different TCRB targets. MRD levels in the follow-up samples from six patients were compared to the results with previously obtained data using other MRD-PCR targets.
Patients P5158, P0807, A6033 and A11039 relapsed after achieving a complete remission (Figure 3) . In patients P5158 and P0807, leukemic cells were detected in all follow-up samples until relapse. Patients A6033 and A11039 apparently had an initial decrease in tumor burden, but MRD was intermittently detectable during therapy and showed a quantitative increase prior to clinical relapse. Comparison of MRD values using two different targets was possible for three of these patients and showed comparable results in two cases. However, in patient P5158 differences in corresponding MRD values were seen. While TCRB and TCRD MRD values in week 3 were almost identical, MRD data in week 22 and at time of clinical relapse (week 50) diverged: values obtained by TCRB RQ-PCR were significantly lower than corresponding TCRD RQ-PCR values. This patient was analyzed in detail for the configuration Table 2 Frequency of Db and Jb usage in TCRB gene rearrangements in childhood and adult T-ALL 2 (5%) Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al Table 4 RQ-PCR analysis of (a) complete (Vb-Db-Jb) and (b) incomplete (Db-Jb) TCRB gene rearrangements in T-ALL patients f Sensitivity: in case nonspecific amplification was observed, the sensitivity was defined as the dilution of the diagnostic sample with the highest threshold cycle (C T ) of at least 1.0 C T lower than the lowest C T of nonspecific amplification. If nonspecific amplification was not observed, the maximal sensitivity was defined as the dilution of the diagnostic sample giving specific amplification. g Repr. range: reproducible range. A dilution of diagnostic sample giving a reproducible C T value (C T variation between two-to four-fold repetitions o2.0) and with the highest C T at least 3.0 C T lower than the lowest C T of nonspecific amplification. h Nonspec. ampl.: nonspecific amplification. The lowest C T value of the nonspecific amplification (if present) is given within parentheses.
Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al of the involved TCRB, TCRG and TCRD genes at diagnosis and relapse. An alteration in TCRB gene rearrangements between diagnosis and relapse was seen, whereas the TCRG and TCRD rearrangements were stable. 28 Patients P5471, P5638, A6526 and A6768 remained in remission. The MRD levels in these four patients showed a rapid decrease and subsequently dropped to levels undetectable by both targets. Minor discrepancies between corresponding MRD values were seen in some samples with residual leukemia close to the detection limit of the assays. In all these cases, MRD was discovered only by one of the two targets at levels below the reproducible range, reflecting differences in the sensitivity of the assays each time (patient P5471, A6526 and A6768: TCRB gene rearrangement represents the more sensitive target; patient P5638: TCRG assay is more sensitive, Figure 3 ).
Discussion
TCRB gene rearrangements are of great interest for clonality assessment and follow-up studies in T-cell malignancies, because their extensive combinatorial repertoire and large hypervariable region theoretically enables a highly specific and sensitive detection of malignant cells. However, the large germline-encoded TCRB repertoire renders PCR assays more difficult for this locus compared to TCRG and TCRD PCR approaches. We recently developed a new and convenient TCRB PCR assay via the BIOMED-2 Concerted Action, 35 which enabled us to develop a simple strategy to detect and sequence clonal TCRB gene rearrangements at the DNA level and to quantify MRD in T-ALL by RQ-PCR analysis. The application of the BIOMED-2 assay in a large series of 100 adult and 53
Figure 3
Applicability of RQ-PCR analysis of TCRB gene rearrangements for MRD detection in follow-up samples of eight patients with T-ALL. RQ-PCR results using clonal TCRB gene rearrangements as targets (squares) were compared to MRD values obtained by RQ-PCR of TCRG or TCRD gene rearrangements (triangles). In patient P5158, the TCRB rearrangement was concluded to be instable (based on mixed heteroduplex analysis of the diagnosis and relapse sample), but appeared to be present in a subclone at relapse as detected by RQ-PCR analysis. RQ-PCR posoRR: RQ-PCR positive, but value below reproducible range; neg: negative (no specific amplification).
Rearranged TCRB genes for MRD quantification in T-ALL M Brüggemann et al childhood T-ALL patients revealed the presence of at least one clonal TCRB gene rearrangement in more than 90% of adult (92/ 100) and childhood (48/53) T-ALL. However, two of the PCRnegative cases were TCRab þ T-ALL, which should demonstrate at least one complete clonal TCRB gene rearrangement. 30 30 analyzed a larger series of 156 T-ALL cases and detected at least one clonal TCRB rearrangement in 88%. Nevertheless, some discrepancies were also found in rearrangement patterns: the total percentage of alleles with complete Vb-Jb rearrangements (52/106 alleles in children and 109/200 alleles in adults) appeared to be somewhat lower than described previously. 30 This may be caused by PCR-related problems: as the diagnostic PCR approach is a multiplex assay, theoretically one of the two clonally rearranged TCRB genes may be preferentially amplified, thereby resulting in an underestimation of the number of biallelic complete rearrangements. In addition, some nonfunctional Vb gene segments are partially not recognized by the BIOMED-2 Vb primer set. 35 Nevertheless, as the overall percentage of PCR detected TCRB-positive T-ALL cases is comparable to those previously discovered by Southern blotting, the BIOMED-2 PCR technique offers a highly useful alternative for defining MRD targets, especially as it is much more rapid, less expensive, requires only small amounts of DNA and allows direct sequencing of clonal rearrangements.
Based on the sequence analysis of a total of 203 clonal TCRB rearrangements, we were able to establish characteristics of TCRB gene rearrangements in adult and childhood T-ALL. Firstly, rearrangements of the TCRBJ2 locus predominated in both groups (69% in adults and 70% in children), which is in accordance with earlier reports based on Southern blot analysis. 24, 29, 30 However, the distribution of Jb2 usage differed between complete and incomplete rearrangements: the percentage of incompletely rearranged alleles involving the Jb2 region was higher in childhood T-ALL (Db-Jb2/Db-Jb1 ratio 3.1) opposed to adults (Db-Jb2/Db-Jb1 ratio 1.4), whereas the percentage of complete Vb-Jb2 rearrangements was decreased in childhood T-ALL (ratio 1.9 vs 3.0). These observations (relative increase in complete Vb-Jb1 and incomplete Db-Jb2 rearrangements) potentially belong together: a complete Vb-Jb1 rearrangement still allows an additional Db2-Jb2 rearrangement on the same allele, whereas no extra Db-Jb rearrangement is possible on the same allele in case of a complete Vb-Jb2 rearrangement. Actually in our series of T-ALL, a complete VbJb1 rearrangement was associated with a Db2-Jb2 recombination in 72% of cases, whereas in case of Vb-Jb2 rearrangements an extra Db2-Jb2 was found in only 27% of cases (Po0.05 by w 2 test). The phenomenon of age-dependent differences in the Jb2/ Jb1 ratio correlates to a finding by Langerak et al 30 , who described discrepancies in the Jb2/Jb1 distribution depending on the immunophenotype of T-ALL: TCRab þ T-ALL exhibited the same differences in Jb2/Jb1 distribution vs immature sCD3
À T-ALL as we observed in childhood T-ALL vs adult T-ALL. This analogy is potentially an additional indication of the more immature T-ALL genotype in adults compared to children. 24 The pattern of Jb segment usage was comparable to that published for peripheral blood lymphocytes in healthy individuals: Jb1.3, Jb1.4, Jb2.4 and Jb2.6, which are rarely used by normal peripheral blood T-lymphocytes 45 were also infrequent (Jb1.3 and Jb1.4) or even absent (Jb2.4 and Jb2.6) in our series of T-ALL. In childhood T-ALL, the Jb2.7 as the most downstream Jb segment was used most frequently, whereas Jb2.3 predominated in adult T-ALL. Theoretically, the complete absence of detectable Jb2.4 or Jb2.6 gene rearrangements could be a failure of the corresponding BIOMED-2 Jb primers. However, in an ongoing investigation of B-lineage ALL, we detected clonal TCRB gene rearrangements containing both Jb gene segments using the BIOMED-2 primer set (data not shown). In addition, every single primer was tested for its function within the scope of the BIOMED-2 Concerted Action. 35 We observed a preferential usage of the more downstream Vb segments in complete rearrangements (Figure 1) . Particularly, the Vb segments TCRBV19, TCRBV20 and TCRBV21 were present in about one-quarter of all complete rearrangements, although a total number of 41 different Vb gene segments was involved in the 126 sequenced TCRB gene rearrangements.
Rearrangements to the most downstream Jb2.7 gene segment do not allow ongoing rearrangements owing to Jb replacement and therefore can be perceived as end-stage recombination events. However, about 20% of T-ALL patients demonstrate clonal evolution of TCRB gene rearrangements. 28 Several clonal evolution phenomena are described, including Vb-Jb replacement. 28 This mechanism requires initial usage of the more downstream Vb gene segments that we found to be rearranged in the majority of complete TCRB gene rearrangements. Oligoclonality is also described as a factor of clonal instability. 26, 28 In our series of T-ALL, we found evidence for subclone formation at the TCRB level in one patient (A12805) due to ongoing Vb to Db-Jb joining, as sequences of an incomplete Db2-Jb2.3 and a complete Vb4.1-Db2-b2.3 rearrangement contained a common Db-Jb stem.
The junctional region diversity was extensive with an NDN region consisting of a mean number of 18 nucleotides without differences between pediatric and adult T-ALL. Incomplete DbJb rearrangements showed a mean of 7.2 inserted nucleotides, which turn also these junctional regions into attractive targets for ASO primers.
In previous studies, we and others already demonstrated the applicability of RQ-PCR assays using ASO primers and consensus probes for sensitive and specific detection of clonal IGH, 10, 11, 16 IGK-Kde, 14 TCRG 13 and TCRD 21,41 rearrangements in patients with ALL. In the present report, we developed a TCRB RQ-PCR assay employing germline Jb region probes and reverse primers in combination with ASO forward primers (Figure 2) . We demonstrate that this PCR method allows a specific, sensitive and reproducible detection of residual tumor cells over a wide range.
Owing to the lack of homology between the different Jb segments, it was necessary to design a specific germline probe and primer for every single Jb gene. In combination with an ASO primer, this RQ-PCR approach allowed to detect one leukemic cell in a background of at least 10 4 normal cells in 56 of the 60 investigated TCRB rearrangements (93%). A sensitivity of 10
À3
was even reached in all cases. Exact quantification up to a level of 10 À4 was possible in 48/60 cases. In contrast to TCRG rearrangements as targets for RQ-PCR-based MRD analysis, 13 nonspecific amplification of normal MNC DNA was not the critical factor for inferior quantification limits. In most cases (5/ 12) C T variations of more than 2.0 between two-to four-fold repetitions of a dilution step limited reproducibility and thus exact quantification of MRD in follow-up samples. Larger variability for samples containing low levels of tumor DNA can be explained by an increased significance of sampling errors and stochastic effects. 13 These factors limit exact MRD quantification in case of low tumor burden, but occur irrespective of the type of target used for quantification and are not associated with the risk of false positivity. Only in five out of 12 rearrangements with a quantification limit not reaching 10 À4 , nonspecific amplification occurred at C T values nearby the 10 À4 dilution, despite optimization of the annealing temperature. All five rearrangements involved Jb2.3, 2.5 or 2.7 segments, which were found to be frequently rearranged in peripheral blood T-lymphocytes. 34, 45 Using the newly developed TCRB RQ-PCR strategy, we quantified MRD in a total of 74 follow-up samples in eight T-ALL patients demonstrating concordance of MRD kinetics with clinical course. Comparative MRD analyses with two different immune gene targets led to comparable results in all but one (P5158) cases. In patient P5158, the TCRB gene rearrangement was concluded to be instable based on heteroduplex analysis of the diagnosis and relapse sample, 28 but appeared to be present in a subclone at relapse by RQ-PCR analysis.
In conclusion, clonal TCRB gene rearrangements are excellent targets for RQ-PCR detection of MRD in T-ALL because of their extensive combinatorial repertoire and large junctional region. Consequently, they represent first choice PCR targets for MRD studies in T-ALL patients. However, clonal evolution can occur, which might be related to the type of TCRB rearrangement and the type of T-ALL. 28 
